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Abstract
Prolonged mechanical ventilation results in diaphragmatic oxida-tive injury, elevated 
proteolysis, fiber atrophy, and reduced force-generating capacity. We tested the hypothesis 
that antioxidant infusion during mechanical ventilation would function as an antioxi-dant to 
maintain redox balance within diaphragm muscle fibers and therefore prevent oxidative stress 
and subsequent proteolysis and contractile dysfunction. Sprague-Dawley rats were anesthe-
tized, tracheostomized, and mechanically ventilated with 21% O2 for 12 hours. The 
antioxidant Trolox was intravenously infused in a subset of ventilated animals. Compared 
with acutely anesthetized, nonventilated control animals, mechanical ventilation resulted in a 
significant reduction (–17%) in diaphragmatic maximal tetanic force. Importantly, Trolox 
completely attenuated this mechanical ventilation-induced diaphragmatic contractile deficit. 
Total dia-phragmatic proteolysis was increased 105% in mechanical ventila-tion animals 
compared with controls. In contrast, diaphragmatic proteolysis did not differ between 
controls and mechanical ventila-tion–Trolox animals. Moreover, 20S proteasome activity in 
the dia-phragm was elevated in the mechanical ventilation animals (+76%); Trolox treatment 
attenuated this mechanical ventilation-induced rise in protease activity. These results are 
consistent with the hypothesis that mechanical ventilation-induced oxidative stress is an 
important factor regulating mechanical ventilation-induced diaphragmatic proteolysis and 
contractile dysfunction. Our findings suggest that antioxidant therapy could be beneficial 
during pro-longed mechanical ventilation.
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Prolonged mechanical ventilation results in diaphragmatic oxida- 
tive injury, elevated proteolysis, fiber atrophy, and reduced force- 
generating capacity. We tested the hypothesis that antioxidant 
infusion during mechanical ventilation would function as an antioxi- 
dant to maintain redox balance within diaphragm muscle fibers 
and therefore prevent oxidative stress and subsequent proteolysis 
and contractile dysfunction. Sprague-Dawley rats were anesthe- 
tized, tracheostomized, and mechanically ventilated with 21% O2 
for 12 hours. The antioxidant Trolox was intravenously infused in 
a subset of ventilated animals. Compared with acutely anesthetized, 
nonventilated control animals, mechanical ventilation resulted in 
a significant reduction  (–17%)  in diaphragmatic maximal  tetanic 
force. Importantly, Trolox completely attenuated this mechanical 
ventilation-induced diaphragmatic contractile deficit. Total dia- 
phragmatic proteolysis was increased 105% in mechanical ventila- 
tion animals compared with controls. In contrast, diaphragmatic 
proteolysis did not differ between controls and mechanical ventila- 
tion–Trolox animals. Moreover, 20S proteasome activity in the dia- 
phragm was elevated in the mechanical ventilation  animals 
(+76%); Trolox treatment attenuated this mechanical ventilation- 
induced rise in protease activity. These results are consistent with 
the hypothesis that mechanical ventilation-induced oxidative stress 
is an important factor regulating mechanical ventilation-induced 
diaphragmatic proteolysis and contractile dysfunction. Our findings 
suggest that antioxidant therapy could be beneficial during pro- 
longed mechanical ventilation. 
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Mechanical ventilation (MV) is used to sustain pulmonary gas 
exchange in patients who are incapable of maintaining adequate 
alveolar ventilation. The withdrawal of MV from patients is 
referred to as “weaning” and problems in weaning from MV 
are common (1). Numerous studies reveal that diaphragmatic 
weakness, due to both diaphragmatic atrophy and contractile 
dysfunction, is an important contributor to weaning difficulties 
(reviewed in References 2 and 3). Hence, developing strategies 
to oppose the deleterious effects of prolonged MV on the dia- 
phragm is an important clinical goal. 
The cellular mechanism(s) responsible for the rapid onset 
of MV-induced diaphragmatic atrophy and weakness remain(s) 
unclear. However, it is possible that MV-induced oxidative stress 
is an important contributor to both MV-induced proteolysis and 
contractile dysfunction. Indeed, our prior work has shown that 
MV is associated with a rapid onset of protein oxidation in 
diaphragm fibers (4, 5). This is significant because oxidative 
stress has been shown to promote disuse muscle atrophy (6, 7), 
and has been directly linked to activation of the ubiquitin– 
proteasome system of proteolysis (8–10). Moreover, oxidative 
stress reduces skeletal muscle force-generating capacity (re- 
viewed in Reid [11]). 
Therefore, the current study determined whether the preven- 
tion of MV-induced oxidative stress in the diaphragm would 
reduce MV-associated diaphragmatic proteolysis and contractile 
dysfunction. We hypothesized that infusion of an antioxidant 
would maintain redox balance within diaphragm muscle fibers 
during MV by functioning as a redox buffer and, thereby, prevent 
oxidative stress and subsequent proteolysis and contractile dys- 
function. 
Prevention of MV-induced oxidative stress in the diaphragm was 
achieved by infusing the antioxidant Trolox [(±)-6-hydroxy-2,5,7,8- 
tetramethylchromane-2-carboxylic acid; Trolox C Fluka/Sigma- 
Aldrich, St. Louis, MO]. Trolox is a water-soluble vitamin E analog 
that freely crosses cell membranes and has antioxidant properties 
(12–14). The effective antioxidant dose and infusion protocol for 
Trolox were determined in a series of preliminary experiments. 
Some of the results of these studies have been previously reported 
in the form of an abstract (15). 
METHODS 
Animals and Experimental Design 
Female Sprague-Dawley rats (5.06 ± 0.12 months old, 284.5 ± 5.1 g) were 
randomly assigned to one of four groups: (1 ) Controls (CON, n = 8), (2 ) 
12 hours of mechanical ventilation and saline infusion (MVS, n = 8), (3 ) 
12 hours of MV and Trolox infusion (MVT, n = 8), and (4 ) 12 hours of 
anesthesia and spontaneous breathing with saline infusion (SBS, n =
8). All procedures were approved by the University of Florida (Gaines- 
ville, FL) Animal Care and Use Committee. 
Control Animal Protocol 
The control animals (CON) were free of intervention before receiving 
an acute intraperitoneal injection of sodium pentobarbital (65 mg/kg 
body weight) before diaphragm excision. 
Mechanical Ventilation Protocol 
Our MV protocol has previously been described (4, 16). Briefly, animals 
were anesthetized with an intraperitoneal injection of sodium pentobar- 
bital (65 mg/kg), tracheostomized and mechanically ventilated (control 
mode; tidal volume, about 0.55 ml/100 g; frequency of breathing, 80 
breaths/minute; positive end-expiratory pressure, 1 cm H2O) with a 
volume-cycled ventilator (Harvard Apparatus, Holliston, MA) for 12 
hours. Body temperature was maintained at 37 ± 1°C. 
Sodium pentobarbital (about 10 mg/kg per hour), and either Trolox 
or saline were infused intravenously during the treatment. Rats were 
continuously supervised and received constant care, including removal 
of airway mucus, passive limb movement, lubrication of the eyes, ex- 
pression of the bladder, and enteral nutrition (Research Diets, New 
Brunswick, NJ). To reduce airway secretions, glycopyrrolate (0.04 mg/kg) 
was injected intramuscularly every 2 hours. 
In the MVT group, a priming dose of Trolox (20 mg/kg) was infused 
over a 5-minute period, 20 minutes before the start of MV. During 
MV, a constant infusion of Trolox at a rate of 4 mg/kg per hour (MVT) 
was maintained. 
At the end of the 12-hour experimental period, the diaphragms were 
removed for immediate measurement of contractile muscle function and 
protein degradation as described below. Unused costal diaphragm tissue 
was frozen for biochemical analyses. 
Spontaneous Breathing Protocol 
Spontaneously breathing (SB) animals were anesthetized and received 
sham surgeries in the same manner as MV animals. These animals were 
tracheostomized and maintained on a surgical plane of anesthesia for 
12 hours while continuing to breathe on their own. 
Contractile Measurements 
The optimal muscle length (Lo), force–frequency relationship, and fatiga- 
bility of in vitro strips excised from the midcostal region of each diaphragm 
were measured as previously described (16, 17). Details of contractile 
muscle function measurements are available in the online supplement. 
Protein  Degradation 
Concurrent with the contractile measurements, the total in vitro protein 
degradation in two separate diaphragm strips per animal was assessed 
by measuring the release of free tyrosine into the incubation medium, 
as previously described (4, 18). Tyrosine in the medium was assayed 
spectrofluorometrically  (19). 
20S Proteasome Activity 
The in vitro chymotrypsin-like activity of the 20S proteasome was mea- 
sured fluorometrically, using techniques described by Stein and coworkers 
(20). 
Total Thiols and Glutathione 
As an indicator of oxidative stress, we measured total thiol groups (21) 
and total glutathione (GSH; Cayman Chemical, Ann Arbor, MI) in the 
costal diaphragm. 
Statistical Analysis 
Group comparisons were made by one-way analysis of variance (Systat 
Software, Point Richmond, CA). Where significant differences were 
found, the Tukey HSD (honestly significantly different) test was imple- 
mented post hoc. Significance was established a priori at p < 0.05.Values 
given are means ± SEM. 
RESULTS 
Systemic and Biologic Responses to Treatment 
The treatment protocol (MV or SB) did not significantly change 
body mass for any of the groups (Table 1), indicating that our 
schedule of nutrition and rehydration was adequate. The ratio 
of total costal diaphragm mass to final body mass was not signifi- 
cantly different between the four groups (p = 0.5). 
There were no signs of infection in any animals, and only 
one MVS animal was eliminated from the study because of 
evidence of barotrauma to the lungs on postmortem examina- 
tion. Systolic blood pressure was maintained at 70–110 mm Hg 
in all groups, and arterial pH, Po2, and Pco2 were maintained 
within physiological ranges for both MV groups as described in 
previous studies from our laboratory (4, 5, 16). The SB animals 
were mildly hypoxic, hypercapnic, and acidotic, an expected 
result postanesthesia. Body temperature was kept at 37 ± 1°C 
during the 12-hour protocol. 
Effects of Anesthesia on Diaphragm Contractile Properties 
The maximal tetanic force was not different between the SBS 
and CON groups (25.09 ± 0.41 versus 25.43 ± 0.50 N/cm2, respec- 
tively; Table 2). Likewise, the force–frequency curves and fatigue 
data were similar between these two groups (Figures 1 and 2), 
and values for contractile parameters did not differ (Table 3). 
Thus, 12 hours of sodium pentobarbital anesthesia did not affect 
in vitro contractile properties of the diaphragm. 
Effects of Mechanical Ventilation on Contractile Properties 
Twelve hours of controlled MV reduced maximal tetanic force 
production by about 17% (21.01 ± 0.71 versus 25.43 ± 0.50 N/cm2 
in CON animals). The force–frequency curve of the MVS group 
was shifted downward and to the right of the CON group (Figure 
1). This indicates a reduction in force generation at all stimula- 
tion frequencies tested. The fatigue protocol produced curves 
of similar shape for all groups (Figure 2), but the MVS group 
generated a significantly lower amount of force compared with 
CON, SBS, and MVT groups where indicated. 
One-half relaxation time (RT1/2) of maximal twitch was sig- 
nificantly shorter in the MVS group compared with CON, 
whereas one-half time to peak tension (TPT1/2), rate of force 
development, and rate of relaxation were not different for either 
maximal twitch or maximal tetanic forces (Table 3). 
Effects of Trolox on Contractile Properties 
Trolox supplementation during 12 hours of MV completely at- 
tenuated the loss of maximal force generation. The MVT group 
was not significantly different from the CON group at any stimu- 
lation frequency tested (Figure 1). Animals receiving Trolox 
during MV maintained a greater force-generating ability after 
the fatigue protocol compared with the unsupplemented MVS 
group (Figure 2). Trolox during MV significantly prolonged the 
rate of relaxation of maximal twitch compared with the CON 
group, but did not affect other contractile parameters (Table 3). 
Protein  Degradation 
Twelve hours of controlled MV significantly elevated total in vitro 
protein degradation (+105%), as measured by the release of free 
tyrosine, compared with the CON group (Figure 3). However, 
protein degradation of the MVT group was not significantly 
different from the CON group (p = 0.797). There were no 
TABLE  1. BODY WEIGHTS OF CONTROL, SPONTANEOUSLY BREATHING, AND MECHANICAL 
VENTILATION ANIMALS 
CON SBS MVS MVT 
Initial body mass, g 
Final body mass, g 
264.38 ± 5.16 
264.38 ± 5.16 
276.88 ± 5.29 
280.56 ± 5.52 
282.25 ± 3.33 
286.38 ± 3.18* 
300.13 ± 6.37*
,†
 
306.75 ± 6.42*
,†
 
Definition of abbreviations: CON = control animals; SBS = spontaneously breathing animals; MVS = mechanical ventilation
animals; MVT = mechanical ventilation animals receiving Trolox. 
Values represent means ± SEM. 
* Significantly different from CON group, p < 0.05.
† 
Significantly different from SBS group, p < 0.05. 
 
 
TABLE  2. DIAPHRAGMATIC MAXIMAL ISOMETRIC TWITCH AND TETANIC FORCE OF CONTROL, 
SPONTANEOUSLY BREATHING, AND MECHANICAL VENTILATION ANIMALS 
 
 CON SBS MVS MVT 
Maximal isometric twitch force, N/cm
2 
Maximal isometric tetanic force, N/cm
2
 
7.24 ± 0.14 
25.43 ± 0.50 
6.79 ± 0.30 
25.09 ± 0.41 
5.65 ± 0.28 *
,†,‡
 
21.01 ± 0.71*
,†,‡
 
7.04 ± 0.25 
25.49 ± 0.50 
For definition of abbreviations see Table 1. 
Values represent means ± SEM. 
* Significantly different from CON group, p < 0.05. 
† 
Significantly different from SBS group, p < 0.05. 
‡ 
Significantly different from MVT group, p < 0.05. 
 
 
significant differences in protein degradation between the CON 
and SBS groups (p = 0.351). 
20S Proteasome Activity 
The chymotrypsin-like activity of the 20S proteasome was sig- 
nificantly increased in the MVS group compared with the CON 
group (+76%) (Figure 4). Trolox attenuated the MV-induced 
increase in proteasome activity (+26% compared with CON, p = 
0.647). 
Oxidative Stress 
Total thiols in the diaphragm were significantly reduced with 12 
hours of MV, indicative of oxidative stress (Table 4). However, 
total thiols were not significantly different between the MVS 
and MVT groups, suggesting that Trolox did not prevent the 
MV-induced reduction in total thiol groups in the diaphragm. 
Similarly, total GSH was significantly reduced after MV treat- 
ment, but total GSH levels in the diaphragm did not differ 
between MVS and MVT treatments (Table 4). 
 
DISCUSSION 
Major Findings 
This is the first investigation to reveal that treatment with the 
antioxidant Trolox can retard the deleterious effects of pro- 
longed MV on the diaphragm. Indeed, our results divulge that 
therapeutic delivery of Trolox during controlled MV attenuates 
both contractile dysfunction and muscle proteolysis in the dia- 
phragm. Moreover, the elevation in MV-induced diaphragmatic 
proteolysis was due, in part, to increased chymotrypsin-like activ- 
ity of the 20S proteasome. Importantly, administration of Trolox 
during MV prevented the MV-induced increase in 20S protea- 
some activity. A brief discussion of these findings follows. 
MV-induced Oxidative Stress in the Diaphragm 
It is well established that unloaded locomotor skeletal muscle 
is susceptible to oxidative stress during periods of disuse (6, 7, 
22). Similarly, during MV, the diaphragm muscle is unloaded or 
inactive, passively shortened, and oxidative injury occurs within 
6 hours of the onset of MV (4, 5). To date, our current or 
previous experiments have not identified the oxidant pathways 
in the diaphragm responsible for MV-induced oxidative stress. 
However, work by Lawler and colleagues (22) reveals that oxida- 
tive stress accompanies the unloading of locomotor skeletal mus- 
cle via a decrease in muscle antioxidant capacity and an increase 
in superoxide and hydrogen peroxide generation. In theory, nu- 
merous oxidant-producing pathways exist in skeletal muscle in- 
cluding mitochondrial, NADPH oxidase, and xanthine oxidase 
pathways. Nonetheless, the specific oxidant-producing pathway 
responsible for disuse-induced redox disturbance in hindlimb 
muscles was not identified in the work of Lawler and coworkers 
(22). Therefore, although it is clear that prolonged MV results 
in oxidative stress in the diaphragm, the pathways responsible 
for this oxidant production are unclear and remain an important 
area for future research. 
In the current experiments, we measured diaphragmatic lev- 
els of total thiols and total GSH as markers of oxidative damage 
in the diaphragm. Our results indicated that MV resulted in 
 
 
 
  
 
Figure 1. Force–frequency curves of in vitro diaphragm strips from con- 
trol (CON), spontaneously breathing (SBS), mechanical ventilation 
(MVS), and mechanical ventilation animals receiving Trolox (MVT). Val- 
ues represent means ± SEM. *Significantly different from CON group, 
p < 0.05; 
+
significantly different from SBS group, p < 0.05; 
#
significantly 
different from MVT group, p < 0.05. 
Figure 2. Comparison of fatigue development of in vitro diaphragm 
strips of control (CON), spontaneously breathing (SBS), mechanical 
ventilation (MVS), and mechanical ventilation animals receiving Trolox 
(MVT) during a 30-minute fatigue protocol. Values represent means ± 
SEM. *Significantly different from CON group, p < 0.05; 
+
significantly 
different from SBS group, p < 0.05; 
#
significantly different from MVT 
group, p < 0.05. 
 
 
TABLE 3. DIAPHRAGMATIC CONTRACTILE PARAMETERS OF MAXIMAL ISOMETRIC TWITCH 
AND TETANIC FORCES OF CONTROL, SPONTANEOUSLY BREATHING, 
AND MECHANICAL VENTILATION ANIMALS 
 
 
CON SBS MVS MVT 
 
 
Twitch 
 
TPT1/2 
RT1/2 
+dp/dt 
0.018 ± 0.000 
0.044 ± 0.001 
332.29 ± 27.368 
0.018 ± 0.001 
0.040 ± 0.001 
420.97 ± 31.176 
0.017 ± 0.000 
0.034 ± 0.003* 
415.85 ± 57.784 
0.018 ± 0.000 
0.04 ± 0.001 
459.52 ± 18.567 
-dp/dt -149.26 ± 9.247 -177.84 ± 9.696 -207.93 ± 28.890 -204.21 ± 7.845* 
  Tetanic   
TPT1/2 
RT1/2 
+dp/dt 
0.064 ± 0.002 
0.064 ± 0.002 
423.71 ± 34.738 
0.062 ± 0.001 
0.062 ± 0.003 
527.67 ± 41.175 
0.056 ± 0.003 
0.062 ± 0.003 
515.38 ± 95.654 
0.059 ± 0.002 
0.065 ± 0.002 
570.18 ± 20.668 
-dp/dt -544.55 ± 50.860 -723.04 ± 36.225 -703.53 ± 157.30 -740.20 ± 12.091 
Definition of abbreviations: +dp/dt = rate of force development; -dp/dt = rate of force relaxation; CON = control animals; 
MVS = mechanical ventilation animals; MVT = mechanical ventilation animals receiving Trolox; RT = relaxation time (milliseconds); 
SBS = spontaneously breathing animals; TPT = time to peak tension (milliseconds). 
Values represent means ± SEM. 
* Significantly different from CON group, p < 0.05. 
 
 
a significant decrease in both markers in the diaphragm; this 
observation is consistent with an increase in oxidative stress in 
the diaphragm (Table 4). However, to our surprise, Trolox did 
not prevent the reduction in both total thiol groups or total GSH 
in the diaphragm during MV. In this regard, it is possible that 
Trolox infusion prevented MV-induced oxidative modification 
of proteins in ways that were not reflected in our measurements 
of total GSH or thiol groups. Oxidative injury can alter cellular 
homeostasis by damaging all types of biomolecules (i.e., DNA, 
lipids, and proteins) (23). It follows that detection of oxidative 
modification of biomolecules is dependent on the assays to mea- 
sure such damage. For example, measurement of total thiols in 
cells would not detect protein damage such as the formation of 
protein carbonyls or protein cross-linking. Moreover, measure- 
ment of total thiols or GSH in the tissue does not indicate 
whether lipid peroxidation occurred in the diaphragm during 
prolonged MV. It is possible that Trolox provided diaphragmatic 
protection against MV-induced oxidative stress, but such protec- 
tion was not detectable by the measurement of total thiols or 
 
 
 
 
 
Figure 3. Effect of mechanical ventilation and Trolox supplementation 
on total in vitro protein degradation as measured by the rate of tyrosine 
release from diaphragm muscle strips per wet weight of muscle in 2 
hours. CON = control; SBS = spontaneously breathing; MVS = mechan- 
ical ventilation; MVT = mechanical ventilation animals receiving Trolox. 
Values represent means ± SEM. *Significantly different from CON 
group, p < 0.05; 
+
significantly different from SBS group, p < 0.05; 
#
significantly different from MVT group, p < 0.05. 
 
GSH alone. Tissue limitations prevented measurement of such 
oxidative injury markers. Nonetheless, we postulate that Trolox 
functioned in our experiments as an antioxidant to prevent MV- 
induced oxidative injury in the diaphragm. In support of this 
notion, numerous studies indicate that Trolox reduces oxidative 
stress in multiple cell types induced by cumene hydroperoxide 
(24), methylmercury intoxication (25), and other oxyradicals 
(12–14, 26). Moreover, Trolox has been shown to reduce oxida- 
tive damage in cardiac muscle during ischemia–reperfusion in- 
sults (14, 27, 28). Collectively, these data support the role of 
Trolox as a biologically active antioxidant. 
MV and Diaphragmatic Contractile Dysfunction 
Our diaphragmatic contractile results (in saline-infused animals) 
agree with previous reports indicating that prolonged MV pro- 
motes diaphragmatic contractile dysfunction in rats (16, 29–31), 
baboons (32), piglets (33), and rabbits (34, 35). In the present 
study, maximal tetanic specific tension was decreased about 17% 
with 12 hours of controlled MV. A new and important finding 
in the current study is that Trolox infusion during MV completely 
attenuated the decrease in both submaximal and maximal spe- 
 
 
 
 
 
Figure 4. Effect of mechanical ventilation and Trolox supplementation 
on chymotrypsin-like activity of the 20S proteasome in the diaphragm of 
control (CON), spontaneously breathing (SBS), mechanical ventilation 
(MVS), and mechanical ventilation animals receiving Trolox (MVT). Val- 
ues represent means ± SEM. *Significantly different from CON group, 
p < 0.05. 
 
 
TABLE  4.  TOTAL  THIOLS  AND  TOTAL  GLUTATHIONE  CONCENTRATIONS  OF  CONTROL, 
SPONTANEOUSLY BREATHING, AND MECHANICAL VENTILATION ANIMALS 
 
 
CON SBS MVS MVT 
 
Total thiols, nmol/mg protein 157.34 ± 6.45 144.06 ± 6.89 134.83 ± 6.90* 122.0 ± 6.45* 
Total GSH, mmol/g 1.15 ± 0.12 0.68 ± 0.05* 0.47 ± 0.08* 0.40 ± 0.05* 
Definition of abbreviations: CON = control animals; GSH = glutathione; MVS = mechanical ventilation animals; MVT = mechanical 
ventilation animals receiving Trolox; SBS = spontaneously breathing animals. 
Values represent means ± SEM. 
* Significantly different from CON group, p < 0.05. 
 
 
cific tension that normally occurs after prolonged MV. Specifi- 
cally, diaphragmatic contractile function in the Trolox-treated 
MV animals did not differ from diaphragmatic function in CON 
or SBS animals with respect to maximal tetanic specific tension, 
maximal twitch specific tension, submaximal specific force pro- 
duction (i.e., 15–60 Hz), and diaphragm fatigue properties. The 
specific mechanism(s) responsible for the Trolox-mediated dia- 
phragmatic protection is unclear but several possibilities exist, 
as detailed below. 
First, oxidative stress-induced changes in calcium regulation 
are a potential contributor to oxidant-mediated contractile dys- 
function (reviewed in Reid [11]). In this regard, it is well estab- 
lished that several sarcoplasmic reticulum proteins are sensitive 
to redox modulation, including the ryanodine-sensitive calcium 
channel (36) and the sarcoplasmic/endoplasmic reticulum calcium- 
dependent ATPase. Indeed, a number of redox sensitive sulfhydryls 
exist near the sarcoplasmic/endoplasmic reticulum calcium- 
dependent ATPase active site and are known to regulate calcium 
pump activity (reviewed in Reid [11]). Generally, oxidative stress 
in skeletal muscles leads to an increase in cytosolic calcium 
levels and a slowed rate of calcium uptake into the sarcoplasmic 
reticulum (11). Paradoxically, we found that the RT1/2 for twitch 
contractions was significantly reduced in the MVS group, sug- 
gesting a greater rate of calcium uptake after MV. The signifi- 
cance of this finding is unclear because no other contractile 
characteristics related to calcium kinetics differed between con- 
trol and MVS. 
Another important  target  for  oxidative  damage  in  muscle 
is myofilaments (37). Several studies reveal that myofilament 
function can be significantly altered by exposure to reactive 
oxygen and nitrogen species (38–40). Several important contrac- 
tile and regulatory proteins could participate in these responses. 
For example, the S1 portion of the myosin heavy chain molecule 
contains several redox-sensitive sites and oxidation could reduce 
the number of myosin cross-bridges in the strong binding state, 
resulting in reduced force production (reviewed in Reid [11]). 
Troponin also exhibits redox sensitivity whereby oxidation could 
influence calcium sensitivity (11). Other myofilaments may also 
exhibit redox sensitivity (e.g., myosin light chains, actin, and 
tropomyosin) but functional details of this redox influence re- 
main poorly defined. 
Finally, it is also possible that MV-induced oxidative stress 
promoted proteolysis in the diaphragm, resulting in degradation 
of important muscle proteins involved in force production. For 
example, degradation of key cytoskeletal or contractile proteins 
could reduce force-generating capacity in the muscle. Our results 
indicate that Trolox administration reduced the rate of total 
muscle proteolysis in the diaphragm during prolonged MV. 
Nonetheless, whether protection against protein breakdown 
played a critical role in the preservation of diaphragmatic force 
production is unclear. 
In summary, the contractile dysfunction produced by oxida- 
tive stress in skeletal muscle may be mediated by oxidant action 
on more than one molecular target. Indeed, the fact that numer- 
 
ous skeletal muscle proteins are redox sensitive argues against 
a single site of redox action in muscle. Hence, it is possible that 
Trolox-mediated protection against MV-induced diaphragmatic 
contractile dysfunction was achieved by the prevention of oxida- 
tive injury at several molecular sites within the muscle. 
MV and Proteolysis 
Twelve hours of controlled MV significantly increased (+105%) 
the release of tyrosine from in vitro diaphragm strips. This agrees 
with a previous study from our laboratory reporting increased 
tyrosine release after 18 hours of MV (4). Because tyrosine is 
neither synthesized nor degraded by skeletal muscle, tyrosine 
release can be used as an indicator of total protein degradation 
(41). In our previous investigation, we determined that 20S pro- 
teasome activity was elevated, indicating a contribution of this 
pathway to diaphragmatic proteolysis during MV (4). 
Importantly, in the  current experiments, Trolox  attenuated 
the increase in total protein degradation induced by MV (Figure 
3). Likewise, the chymotrypsin-like activity of the 20S protea- 
some was elevated during MV, but this increase was prevented 
with Trolox (Figure 4). Many studies indicate that the protea- 
some is responsible for about 70–80% of the increased cellular 
protein degradation after an oxidative stress (8, 9, 42). More 
specifically, it appears the 20S proteasome is responsible for the 
degradation of oxidized proteins because the 26S proteasome 
can be inhibited by oxidative stress (43). Recognition of exposed 
hydrophobic patches is the proposed mechanism by which the 
proteasome selectively degrades oxidatively modified proteins 
(44). Oxidative damage to a protein leads to partial unfolding 
and exposure of normally shielded internal hydrophobic patches 
that are recognized by the proteasome, which catalyzes the deg- 
radation of that protein. 
The diaphragmatic atrophy and contractile dysfunction that 
occur with prolonged MV are likely the result of increased oxida- 
tive modification of proteins, leading to proteolytic attack and 
degradation. This loss of protein, especially contractile protein, 
would result in atrophy and decreases in maximal force produc- 
tion. Clinically, this would manifest as difficulty in weaning from 
the mechanical ventilator. 
Conclusions 
Our results support earlier conclusions that short-term con- 
trolled MV leads to diaphragmatic contractile dysfunction and 
increased protein degradation. Importantly, our novel results 
clearly demonstrate that an antioxidant, Trolox, effectively pre- 
vents MV-induced contractile impairments and proteolysis in 
the diaphragm during MV. Oxidative damage and atrophy are 
implicated in MV-induced contractile deficits. Oxidative damage 
to proteins during MV likely increases proteolytic degradation, 
which would contribute to diaphragmatic weakness. Trolox ef- 
fectively spares the unloaded diaphragm from contractile dys- 
function and protein degradation during 12 hours of controlled 
MV. The use of an antioxidant such as Trolox may prove benefi- 
cial in the clinical setting, where weaning difficulties are encoun- 
 
 
tered due to diaphragmatic atrophy and weakness. This is an 
important clinical issue that warrants further investigation. 
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